BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 17995980)

  • 1. E-PTFE (Gore-Tex) implant with or without low-dosage mitomycin-C as an adjuvant in penetrating glaucoma surgery: 2 year randomized clinical trial.
    Cillino S; Zeppa L; Di Pace F; Casuccio A; Morreale D; Bocchetta F; Lodato G
    Acta Ophthalmol; 2008 May; 86(3):314-21. PubMed ID: 17995980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep sclerectomy versus trabeculectomy with low-dosage mitomycin C: four-year follow-up.
    Cillino S; Di Pace F; Casuccio A; Cillino G; Lodato G
    Ophthalmologica; 2008; 222(2):81-7. PubMed ID: 18303227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep sclerectomy versus punch trabeculectomy: effect of low-dosage mitomycin C.
    Cillino S; Di Pace F; Casuccio A; Lodato G
    Ophthalmologica; 2005; 219(5):281-6. PubMed ID: 16123554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trabeculectomy with or without mitomycin-C for paediatric glaucoma in aphakia and pseudophakia following congenital cataract surgery.
    Mandal AK; Bagga H; Nutheti R; Gothwal VK; Nanda AK
    Eye (Lond); 2003 Jan; 17(1):53-62. PubMed ID: 12579171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of adjunctive mitomycin C during Ahmed Glaucoma Valve implantation: a prospective randomized clinical trial.
    Costa VP; Azuara-Blanco A; Netland PA; Lesk MR; Arcieri ES
    Ophthalmology; 2004 Jun; 111(6):1071-6. PubMed ID: 15177955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trabeculectomy with mitomycin C: outcomes and risk factors for failure in phakic open-angle glaucoma.
    Fontana H; Nouri-Mahdavi K; Lumba J; Ralli M; Caprioli J
    Ophthalmology; 2006 Jun; 113(6):930-6. PubMed ID: 16647135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep sclerectomy with mitomycin C in failed trabeculectomy.
    Rebolleda G; Muñoz-Negrete FJ
    Eye (Lond); 2007 Jan; 21(1):23-8. PubMed ID: 16311522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cumulative effect of risk factors on short-term surgical success of mitomycin augmented trabeculectomy.
    Agarwal HC; Sharma TK; Sihota R; Gulati V
    J Postgrad Med; 2002; 48(2):92-6. PubMed ID: 12215687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes of intraoperative 5-fluorouracil versus intraoperative mitomycin C in primary trabeculectomy surgery.
    Palanca-Capistrano AM; Hall J; Cantor LB; Morgan L; Hoop J; WuDunn D
    Ophthalmology; 2009 Feb; 116(2):185-90. PubMed ID: 18930550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of antimetabolites in filtration surgery for neovascular glaucoma: intermediate-term follow-up.
    Sisto D; Vetrugno M; Trabucco T; Cantatore F; Ruggeri G; Sborgia C
    Acta Ophthalmol Scand; 2007 May; 85(3):267-71. PubMed ID: 17488455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and complications after trabeculectomy with mitomycin C in normal-tension glaucoma.
    Jongsareejit B; Tomidokoro A; Mimura T; Tomita G; Shirato S; Araie M
    Jpn J Ophthalmol; 2005; 49(3):223-7. PubMed ID: 15944828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subconjunctival sodium hyaluronate 2.3% in trabeculectomy: a prospective randomized clinical trial.
    Lopes JF; Moster MR; Wilson RP; Altangerel U; Alvim HS; Tong MG; Fontanarosa J; Steinmann WC
    Ophthalmology; 2006 May; 113(5):756-60. PubMed ID: 16650669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protocol for mitomycin C use in glaucoma surgery.
    Maquet JA; Dios E; Aragón J; Bailez C; Ussa F; Laguna N
    Acta Ophthalmol Scand; 2005 Apr; 83(2):196-200. PubMed ID: 15799732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized comparison of the intraocular pressure-lowering effect of phacoviscocanalostomy and phacotrabeculectomy.
    Kobayashi H; Kobayashi K
    Ophthalmology; 2007 May; 114(5):909-14. PubMed ID: 17397924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep sclerectomy augmented with mitomycin C.
    Anand N; Atherley C
    Eye (Lond); 2005 Apr; 19(4):442-50. PubMed ID: 15746961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the role of subconjunctival versus intrascleral application of mitomycin C in high-risk trabeculectomies.
    Agarwal HC; Saigal D; Sihota R
    Indian J Ophthalmol; 2001 Jun; 49(2):91-5. PubMed ID: 15884512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Artificial trabeculum (MESH). Clinical and histological study in the rabbit].
    Helies P; Legeais JM; Savoldelli M; Parel JM; Renard G
    J Fr Ophtalmol; 1998 May; 21(5):351-60. PubMed ID: 9759429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of early IOP in mitomycin-C augmented trabeculectomy.
    Alwitry A; Moodie J; Rotchford A; Abedin A; Patel V; King AJ
    J Glaucoma; 2007; 16(7):616-21. PubMed ID: 18091180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of initial trabeculectomy with mitomycin C for primary open-angle glaucoma in Japanese patients.
    Shigeeda T; Tomidokoro A; Chen YN; Shirato S; Araie M
    J Glaucoma; 2006 Jun; 15(3):195-9. PubMed ID: 16778640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes of repeat vs initial trabeculectomy in open-angle glaucoma.
    Law SK; Shih K; Tran DH; Coleman AL; Caprioli J
    Am J Ophthalmol; 2009 Nov; 148(5):685-695.e1. PubMed ID: 19596220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.